Ex-CEO of Insys to Plead Guilty in Major Opioid Case - NBC Connecticut
National & International News
The day’s top national and international news

Ex-CEO of Insys to Plead Guilty in Major Opioid Case

Insys executives allegedly defrauded insurance companies through their actions because the insurance providers made payments to doctors without knowledge of the bribes and kickbacks

    processing...

    NEWSLETTERS

    The Opioid Crisis: By the Numbers

    A study of the opioid epidemic reveals some disturbing numbers.

    (Published Wednesday, Oct. 17, 2018)

    The former CEO of a drug company that produced a powerful and addictive painkiller containing fentanyl for cancer patients has agreed to plead guilty in connection with a scheme in which the firm's leaders bribed doctors in return for their prescribing the drug, court documents filed Wednesday show.

    Michael Babich, a former president and CEO of the Arizona-based Insys Therapeutics Inc., producer of the drug Subsys, will plead guilty to one count of conspiracy and one count of mail fraud for his role in the alleged conspiracy, according to court documents.

    As NBC News reported, Insys executives allegedly defrauded insurance companies through their actions because the insurance providers made payments to doctors without knowledge of the bribes and kickbacks, according to court documents filed by the Andrew Lelling, the U.S. Attorney for Massachusetts. 

    "The bribes and kickbacks took multiple forms," the prosecutor's motion filed Wednesday states. Babich and other company executives allegedly paid doctors fees that were purportedly for speaking engagements. They also allegedly hired and paid the salaries of some office staff for "certain targeted practitioners."